Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9

Abstract

A gene critical to esophageal cancer has been identified. Functional studies using microcell-mediated chromosome transfer of intact and truncated donor chromosomes 3 into an esophageal cancer cell line and nude mouse tumorigenicity assays were used to identify a 1.61 Mb tumor suppressive critical region (CR) mapping to chromosome 3p14.2. This CR is bounded by D3S1600 and D3S1285 microsatellite markers. One candidate tumor suppressor gene, ADAMTS9, maps to this CR. Further studies showed normal expression levels of this gene in tumor-suppressed microcell hybrids, levels that were much higher than observed in the recipient cells. Complete loss or downregulation of ADAMTS9 gene expression was found in 15 out of 16 esophageal carcinoma cell lines. Promoter hypermethylation was detected in the cell lines that do not express this gene. Re-expression of ADAMTS9 was observed after demethylation drug treatment, confirming that hypermethylation is involved in gene downregulation. Downregulation of ADAMTS9 was also found in 43.5 and 47.6% of primary esophageal tumor tissues from Hong Kong and from the high-risk region of Henan, respectively. Thus, this study identifies and provides functional evidence for a CR associated with tumor suppression on 3p14.2 and provides the first evidence that ADAMTS9, mapping to this region, may contribute to esophageal cancer development.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Chen WY, Baylin SB . (2005). Cell Cycle 4: 10–12.

  • Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI et al. (1998). Proc Natl Acad Sci USA 95: 3042–3047.

  • Cheung AL, Si HX, Wang LD, An JY, Tsao SW . (2005). Cancer Lett (in press).

  • Clark ME, Kelner GS, Turbeville LA, Boyer A, Arden KC, Maki RA . (2000). Genomics 67: 343–350.

  • Deng W, Tsao SW, Guan XY, Lucas JN, Si HX, Leung CS et al. (2004). Oncogene 23: 9090–9101.

  • Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskeva C et al. (1992). Mol Cell Biol 12: 1387–1395.

  • Hesson L, Bieche I, Krex D, Criniere E, Hoang-Xuan K, Maher ER et al. (2004). Oncogene 23: 2408–2419.

  • Horiguchi K, Tomizawa Y, Tosaka M, Ishiuchi S, Kurihara H, Mori M et al. (2003). Oncogene 22: 7862–7865.

  • Hu CP, Hsieh HG, Chien KY, Wang PY, Wang CI, Chen CY et al. (1984). J Natl Cancer Inst 72: 577–583.

  • Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL et al. (2002). Cancer Genet Cytogenet 135: 120–127.

  • Ko JM, Wong CP, Tang CM, Lau KW, Lung ML . (2001). Cancer Lett 170: 131–138.

  • Ko JM, Yau WL, Chan PL, Lung HL, Yang L, Lo PH et al. (2005). Genes Chromosomes Cancer 43: 284–293.

  • Li JY . (1982). Natl Cancer Inst Monogr 62: 113–120.

  • Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI et al. (2006). Cancer Lett 234: 184–192.

  • Lung HL, Bangarusamy DK, Xie D, Cheung AKL, Cheng Y, Kumaran MK et al. (2005). Oncogene 24: 6525–6532.

  • Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY et al. (2004). Int J Cancer 112: 628–635.

  • Mok CH, Chew EC, Riches DJ, Lee JC, Huang DP, Hadgis C et al. (1987). Anticancer Res 7: 409–415.

  • Pan QQ . (1989). Proc Chin Acad Med Sci Peking Union Med Coll 4: 52–57.

  • Porter S, Scott SD, Sassoon EM, Williams MR, Jones JL, Girling AC et al. (2004). Clin Cancer Res 10: 2429–2440.

  • Qin YR, Wang LD, Kwong D, Gao SS, Guan XY, Zhuang ZH et al. (2005). Zhonghua Bing Li Xue Za Zhi 34: 80–83.

  • Rimessi P, Gualandi F, Morelli C, Trabanelli C, Wu Q, Possati L et al. (1994). Oncogene 9: 3467–3474.

  • Rooney DE . (1986). In Human Cytogenetics: A Practical Approach. Czeoulkowski BM (ed). IRL Press: Washington, DC.

    Google Scholar 

  • Sambrook J, Fritsch EF, Maniatis T . (1989). Molecular Cloning. Cold Spring Harbor Laboratory Press: NY.

    Google Scholar 

  • Saxon PJ, Srivatsan ES, Leipzig GV, Sameshima JH, Stanbridge EJ . (1985). Mol Cell Biol 5: 140–146.

  • Sekine I, Sato M, Sunaga N, Toyooka S, Peyton M, Parsons R et al. (2005). Oncogene 24: 2735–2738.

  • Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T . (1992). Cancer 69: 277–284.

  • Shiomi H, Sugihara H, Kamitani S, Tokugawa T, Tsubosa Y, Okada K et al. (2003). Cancer Genet Cytogenet 147: 50–61.

  • Somerville RP, Longpre JM, Jungers KA, Engle JM, Ross M, Evanko S et al. (2003). J Biol Chem 278: 9503–9513.

  • Takahashi K, Kanazama H, Chan CT . (1990). Jpn J Oral Maxillofac Surg 36: 307–316.

  • Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC et al. (1998). Genes Chromosomes Cancer 23: 123–133.

  • Tang JC, Wan TS, Wong N, Pang E, Lam KY, Law SY et al. (2001). Cancer Genet Cytogenet 124: 36–41.

  • Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, Mirmohammadsadegh A et al. (2005). Int J Cancer 115: 684–689.

  • Uzawa N, Yoshida MA, Hosoe S, Oshimura M, Amagasa T, Ikeuchi T . (1998). Cancer Genet Cytogenet 107: 125–131.

  • Wang L, Li W, Wang X, Zhang C, Zhang T, Mao X et al. (1996). Oncogene 12: 699–703.

  • Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL et al. (2004). Cancer Res 64: 1972–1974.

  • Yang L, Leung AC, Ko JM, Lo PH, Tang JC, Srivastava G et al. (2005). Oncogene 24: 697–705.

  • Yang Y, Kost-Alimova M, Ingvarsson S, Qianhui Q, Kiss H, Szeles A et al. (2001). Proc Natl Acad Sci USA 98: 1136–1141.

Download references

Acknowledgements

We acknowledge the financial support of the Research Grants Council of the Hong Kong Special Administration Region, China to MLL (HKUST6106/00M).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M L Lung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lo, P., Leung, A., Kwok, C. et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 26, 148–157 (2007). https://doi.org/10.1038/sj.onc.1209767

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209767

Keywords

This article is cited by

Search

Quick links